Zerit / Jean Rosenthal, Ian Shapiro, Jaan Elias.

Format:

Book

Author/Creator:

Rosenthal, Jean, active 2017, author.

Shapiro, Ian, author.

Elias, Jaan, author.

Series:

SAGE Knowledge. Cases.

SAGE Knowledge. Cases

Language:

English

Subjects (All):

Yale University.

AIDS vaccines--South Africa.

AIDS vaccines.

Soderstrom, Jon.

Yale University. Office of Cooperative Research.

Zerit.

Bristol-Myers Squibb Company.

South Africa.

Physical Description:

1 online resource.

Place of Publication:

London : Yale School of Management, 2017.

System Details:

text file

Summary:

In 2001, Jon Soderstrom, Director of Yale's Office of Cooperative Research, found himself in the midst of a maelstrom of negative publicity. Yale's patent on the drug Zerit had become the target of international activists and campus protests. Protestors asserted that the patent and Yale's licensing of the pharmaceutical to Bristol-Myers Squibb (BMS) was preventing low-cost generics from reaching millions suffering from HIV/AIDS in South Africa. After a meeting between Soderstrom and BMS, BMS lowered the price of Zerit in South Africa and other developing countries and the crisis cooled. But student protestors and others continued to question university policy on the use of patents in the development of new pharmaceuticals, the close relationship between big pharma and universities, and the ethics and goals of university research.

Notes:

Originally published in Shapiro, I., & Elias, J. (2017). Zerit. 17-011. New Haven, CT: Yale School of Management, Yale University. Retrieved from: http://vol11.cases.som.yale.edu/zerit.

No ILL or scholarly sharing allowed.

Description based on XML content.

ISBN:

9781526429773

OCLC:

44258641

Access Restriction:

Restricted for use by site license.